AIC
TXG icon

Ameritas Investment Company’s 10x Genomics TXG Stock Holding History

Ameritas Investment Company’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$3.7M Hold
25,418
– – 0.17% 105
2021
Q2 		$4.98M Sell
25,418
-4,999
-16% -$905K 0.24% 68
2021
Q1 		$5.51M Buy
+30,417
New +$5.25M 0.48% 49

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
MCAV
Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameritas Investment Company's TXG Position: Q3 2021 in Review

Ameritas Investment Company held its 10x Genomics (TXG) position steady in Q3 2021 at 25,418 shares worth $3.7M. The position accounts for 0.17% of the portfolio, ranked #105.

Ameritas Investment Company first reported a position in TXG in Q1 2021 and has held it in 3 quarters since. The position peaked at $5.51M in Q1 2021. 330 funds tracked by Wall St. Rank hold TXG as of Q3 2021.

  • Ameritas Investment Company held 25,418 shares of 10x Genomics worth $3.7M as of Q3 2021.
  • Ameritas Investment Company left its 10x Genomics share count unchanged in Q3 2021.
  • 10x Genomics made up 0.17% of Ameritas Investment Company's portfolio in Q3 2021, its #105 holding.
  • Ameritas Investment Company first reported a position in 10x Genomics in Q1 2021 and has held it in 3 quarters since.
  • Ameritas Investment Company's 10x Genomics position peaked at $5.51M in Q1 2021.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.